Author

Tricia Blankenbiller

Observed names: Blankenbiller, Tricia, T. Blankenbiller

Observed institutions: Thomas Jefferson University, King's College London, Novartis (United States), Mayo Clinic in Arizona, BridgeBio (United States), Teva Pharmaceuticals (United States), Wellcome Trust

ORCID: 0009-0009-9973-4744

Observed ORCID: 0009-0009-9973-4744

OpenAlex ID: A5041587271

Fremanezumab for the Preventive Treatment of Chronic Migraine

2017 · Stephen D. Silberstein, David W. Dodick, et al. · New England Journal of Medicine · 794

Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine

2018 · David W. Dodick, Stephen D. Silberstein, et al. · JAMA · 564

PDF

Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine

2019 · Paul K. Winner, Egilius L. H. Spierings, et al. · Headache The Journal of Head and Face Pain · 47

Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraine

2019 · Jan Lewis Brandes, David Kudrow, et al. · Cephalalgia · 23

O19 Preliminary results from MLB-01-003: an open label phase 2 study of BBP-418 in patients with limb-girdle muscular dystrophy type 2I/R9

2023 · A. Harper, R. Langeslay, et al. · Neuromuscular Disorders · 6

Early Onset of Action with Fremanezumab Versus Placebo for the Preventive Treatment of Episodic Migraine (P4.107)

2018 · Jan Brandes, Paul P. Yeung, et al. · Neurology · 3

Early Onset of Action with Fremanezumab Versus Placebo for the Preventive Treatment of Chronic Migraine (P4.102)

2018 · Paul P. Yeung, Ernesto Aycardi, et al. · Neurology · 2

Quantitative Measurement of Glycosylated ⍺-Dystroglycan as a Biomarker for Disease Severity in Limb-Girdle Muscular Dystrophy Type 2I/R9

2026 · John Vissing, Tahseen Mozaffar, et al. · Neurology Genetics · 1

PDF

Efficacy of Fremanezumab in Patients With Episodic Migraine Who Had Prior Use of Topiramate or OnabotulinumtoxinA (P4.110)

2018 · David Kudrow, Fumihiko Sakai, et al. · Neurology · 1

Baseline Characteristics And Interim Analysis Results Of The Fingolimod Cohort In The World-Wide Post-Approval Safety Program (PASSAGE) (P2.202)

2014 · Paul Giacomini, Helmut Butzkueven, et al. · Neurology · 1

21O Interim analysis from the ongoing Phase 3 FORTIFY study of BBP-418 for individuals living with LGMD2I/R9 suggests benefit across functional and cardiac endpoints

2026 · Damon Bass, Katherine D. Mathews, et al. · Neuromuscular Disorders

MLB-01-003

2026 · Amy Harper, Ruby Langeslay, et al. · Neurology Open Access

PDF

575P FORTIFY: a phase 3 study to evaluate efficacy & safety of BBP-418 in individuals with Limb-Girdle muscular dystrophy 2I, LGMDR9 FKRP-related (LGMD2I/R9)

2024 · D. Sproule, D. Reddy, et al. · Neuromuscular Disorders

Increased survival in MoCD type A patients treated with cPMP when compared to a natural history cohort

2021 · Nils Confer, Donald Basel, et al. · Molecular Genetics and Metabolism

Efficacy of Fremanezumab in Patients With Chronic Migraine Who Had Prior Use of Topiramate or OnabotulinumtoxinA (P4.104)

2018 · Paul P. Yeung, Egilius L. H. Spierings, et al. · Neurology

Efficacy of Two Dose Regimens of Subcutaneous Fremanezumab Versus Placebo for the Preventive Treatment of Chronic Migraine (S32.005)

2018 · Stephen Silberstein, Ernesto Aycardi, et al. · Neurology

Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab Versus Placebo for the Preventive Treatment of Episodic Migraine (P4.093)

2018 · David Dodick, Ernesto Aycardi, et al. · Neurology

Impact of Fremanezumab on the Number of Days With Use of Acute Headache Medications in Episodic Migraine (P4.106)

2018 · Jan Brandes, Fumihiko Sakai, et al. · Neurology

Achievement of Response with Fremanezumab in the Treatment of Chronic Migraine (P4.113)

2018 · Paul K. Winner, Marcelo E. Bigal, et al. · Neurology

Impact of Fremanezumab on the Number of Days with Use of Acute Headache Medications in Chronic Migraine (P4.101)

2018 · Ernesto Aycardi, Paul P. Yeung, et al. · Neurology

Efficacy Of Fremanezumab in Patients With Chronic Migraine With or Without Concomitant Use of Preventive Medication (P4.099)

2018 · Peter J. Goadsby, David W. Dodick, et al. · Neurology

Works count: 22

Citation count: 1,442

H-index: 5

I10-index: 4